Participants in Fresenius Medical Care North America’s 401(k) plan advanced their challenge to the company’s handling of plan forfeitures, after a Massachusetts federal judge aligned himself with the ...
Under the collaboration, Phlow will produce the U.S.-based API, while Fresenius Kabi will manufacture the finished doses for hospitals and clinics across the country.
WARN notice cites logistics divestiture to Ryder System, with job cuts expected April 10.
Fresenius continues to hammer Akorn with allegations of fraud in its drug development and manufacturing as the German company battles to extract itself from its $4.3 billion buyout of the U.S. sterile ...
9don MSN
Fresenius Medical Care to lay off dozens of cross-dock employees at Oregon distribution center
Fresenius Medical Care is laying off 54 cross-dock workers from its distribution center at 555 Blue Heron Drive in Oregon, ...
Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...
One stock that might be an intriguing choice for investors right now is Fresenius Medical Care AG FMS. This is because this security in the Medical - Instruments space is seeing solid earnings ...
Zacks Investment Research on MSN
Here's why Fresenius (FMS) is a strong value stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services, and a solid global foothold. However, stiff competition remains a ...
Fresenius reported solid results for fiscal 2022, but keeps missing its own growth target - at least for the bottom line. The company is also losing its status as dividend aristocrat and is keeping ...
Fresenius reported mediocre results and suspended the dividend this year, but management is optimistic for fiscal 2024. The company will focus on reducing debt levels in 2024 and the deconsolidation ...
Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results